Clinical Trials Logo

Clinical Trial Summary

The thymus gland is a specialized organ in the chest that plays a central role in the adaptive immune system throughout development until puberty. In response to stress, the fetal thymus gland may shrink, or involute. The investigators propose a prospective cohort study that will enroll pregnant women admitted to labor and delivery for the management of preterm labor and/or preterm premature rupture of membranes from 28-36 weeks gestation. Based on sonographic thymus measurements, the investigators will develop a clinical prediction tool to identify babies who are at increased risk for adverse neonatal outcomes. A reliable non-invasive predictor of adverse neonatal outcome using thymic ultrasound measurements has the potential to affect clinical management, improve outcomes for premature babies, and direct further research efforts.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01975792
Study type Observational
Source University of Pennsylvania
Contact
Status Completed
Phase N/A
Start date March 2013
Completion date April 2014